Cedara Software notches double-digit revenue growth and profit

A 40 percent decline in expenses from the year-ago quarter helped Cedara Software Corp. post a profit in its second fiscal quarter, ending Dec. 31, 2003.

Revenues increased 47 percent to approximately $9.1 million, compared with approximately $6.1 million in the second quarter of FY03. The Canadian PACS software form posted net income of approximately $2.9 million, compared with a net loss of approximately $2.9 million in the year-ago quarter.

For the six-month period, revenues escalated to approximately $16.7 million, compared with approximately $11 million in the same period of FY03. Net income totaled approximately $4.2 million, compared with a net loss of approximately $6 million in the year-ago period.

Operating expenses of approximately $4 million in the second quarter declined by approximately $2.6 million, compared to the year-ago quarter. Cedara cited one-time recoveries of approximately $1 million against provisions taken in earlier quarters, as well as severance costs in FY03 amounting to a charge of approximately $1.2 million.

All dollar amounts are converted into U.S. currency.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.